Cixutumumab imc a12 ottobre 2010

Cixutumumab (IMC-A12), a fully human IgG1 monoclonal antibody to the insulin-like growth factor I receptor (IGF-IR) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Rowinsky EK, Youssoufian H, Tonra JR, Solomon P, Burtrum D, Ludwig DL. IMC-A12, a human IgG1 monoclonal antibody to the insulin-like growth factor I receptor. Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5549s-5555s. IgG1 IGF-1 IGF-2 Antiproliferative Proapoptotic Necrosis Cell Death PI3K Akt mTOR BAD PDK1 IRS-1 IRS-1 Ras SOS Grb2 Raf MEK ERK 1 2 3 IMC-A12 Macrophage

IGF-1R pathway in lung cancer ,[object Object],[object Object],[object Object],[object Object],Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008 Dec;8(12):915-28. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst. 1999 Jan 20;91(2):151-6. London SJ, Yuan JM, Travlos GS, Gao YT, Wilson RE, Ross RK, Yu MC. Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China. J Natl Cancer Inst. 2002 May 15;94(10):749-54. D. T. Merrick, R. Dziadziuszko, B. Szostakiewicz, A. Szymanowska, W. Rzyman, E. Jassem, J. Jassem, W. A. Franklin, P. A. Bunn, Jr. and F. R. Hirsch. High insulin-like growth factor 1 receptor (IGF1R) expression is associated with poor survival in surgically treated non-small cell lung cancer (NSCLC) patients (pts). Abstract Journal of Clinical Oncology , 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 25, No 18S (June 20 Supplement), 2007: 7550 Rafal Dziadziuszko, Daniel T. Merrick, Samir E. Witta, Adelita D. Mendoza, Barbara Szostakiewicz, Amelia Szymanowska, Witold Rzyman, Katarzyna Dziadziuszko, Jacek Jassem, Paul A. Bunn Jr, Marileila Varella-Garcia and Fred R. Hirsch. Insulin-like Growth Factor Receptor 1 (IGF1R) Gene Copy Number Is Associated With Survival in Operable Non–Small-Cell Lung Cancer: A Comparison Between IGF1R Fluorescent In Situ Hybridization, Protein Expression, and mRNA Expression . J Clin Oncol. 2010 May 1;28(13):2174-80.

Cixutumumab (IMC-A12): ongoing phase II s tudies in lung cancer ,[object Object],[object Object],[object Object],Gemcitabine / Carboplatin/ Cetuximab + IMC-A12 Gemcitabine / Carboplatin/ Cetuximab Cetuximab + IMC-A12 Cetuximab ORR N=90 ,[object Object],[object Object],[object Object],[object Object],Carboplatin / Paclitaxel / Bevacizumab + IMC-A12 Carboplatin / Paclitaxel / Bevacizumab Bev + IMC-A12 Bev PFS N=180 1 2 1 1 ,[object Object],[object Object],[object Object],[object Object],Carboplatin / Paclitaxel / Cetuximab Cetux PFS N=200 Carboplatin / Paclitaxel / IMC-A12 Carboplatin / Paclitaxel / Cetuximab / IMC-A12 1 1 1 IMC-A12 Cetux / IMC-A12 ,[object Object],[object Object],[object Object],Erlotinib + IMC-A12 Erlotinib (optional crossover at PD) Erlotinib + IMC-A12 PFS N=120 1 1 Safety Lead-in ,[object Object],[object Object],[object Object],Cisplatin / Etoposide PFS N=170 Cisplatin / Etoposide + IMC-A12 Cisplatin / Etoposide + GDC-0449 1 1 1 IMC-A12 GDC-0449 www.clinicaltrials.gov ; accessed on August 27 th , 2010

Cixutumumab imc a12 ottobre 2010

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Cixutumumab imc a12 ottobre 2010

Similar to Cixutumumab imc a12 ottobre 2010 (20)

More from coolesanum

More from coolesanum (10)

Recently uploaded

Recently uploaded (20)

Cixutumumab imc a12 ottobre 2010